Back to ExodusPoint Capital Management, LP ExodusPoint Capital Management, LP

IOVAIOVA

Showing 6 of 21 quarters

Position history for ExodusPoint Capital Management, LPExodusPoint Capital Management, LP's holdings in Iovance Biotherapeutics, Inc.

Yes. ExodusPoint Capital Management holds 270,655 shares of IOVA (Iovance Biotherapeutics), worth $1.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$1.1M

Current Shares

270,655

Total Value Change

-$2.8M

Total Shares Change

-900,090

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
270,655
—
$1.1M0.0%$4.16
35
2026-Q1
Exited
0
-100.0%
$00.0%$3.51
0
2025-Q4
Increased
281,477
+568.2%
$768,4320.0%$2.73
40
2025-Q3
New
42,123
—
$91,4070.0%$2.17
30
2025-Q2
Exited
0
-100.0%
$00.0%$1.72
0
2025-Q1
New
1.2M
—
$3.9M0.0%$3.33
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used